The Survival Implications of Bone Mineral Loss
In a Town Hall discussion, “Ablating Testosterone in Prostate Cancer and the Concomitant Negative Effects”, Fred Saad, MD, FRCS, Director of Urologic Oncology, Professor of Surgery/Urology, U of M Chair in Prostate Cancer; University of [...]
When to Call the Doctor During Prostate Cancer Treatment – Learning about Infections and Deep Vein Thrombosis
Having prostate cancer and prostate cancer treatments may cause side effects that require the immediate attention of your doctor or health care team, but it is hard to know when to call the doctor as [...]
Prostate Cancer with a Gleason 7 – Different Outcomes Between Gleason 4 + 3 and Gleason 3 + 4 – Changing Treatment Directions
A Gleason Score of 7 is often looked at as a middle range score, but clearly not as serious as an 8 or 9 score. Some recently combined research performed at the Department of Urology, [...]
Stereotactic Radio Surgery (SRS) Successfully Treats Pain in Patients with Advanced Cancer that has Spread to Bones
According to researchers from University of Pittsburgh Cancer Institute (UPCI), Stereotactic Radio Surgery (SRS), which was developed at UPCI, can successfully control pain in patients with cancer that has spread to the spine. SRS is [...]
On the Horizon – A Quick Summary of the Status of Some of the Up Coming Treatments for Advanced Prostate Cancer
Provenge, a cancer vaccine, has demonstrated its ability to improve the survival of men with castrate resistant prostate cancer (CRPC). The developer, Dendreon, has submitted it latest clinical trial data to the FDA for approval. [...]
Rapid PSA Decline After Docetaxel Chemotherapy is Associated with Improved Survival in Hormone Refractory Prostate Cancer
A chart review performed at the Department of Internal Medicine, University of Alberta, Edmonton, AB. concluded that the a quick rate of initial PSA decline in men with hormone refractory prostate cancer receiving docetaxel chemotherapy [...]